| Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia A Yoda, Y Yoda, S Chiaretti, M Bar-Natan, K Mani, SJ Rodig, N West, ... Proceedings of the National Academy of Sciences 107 (1), 252-257, 2010 | 403 | 2010 |
| Dasatinib–blinatumomab for Ph-positive acute lymphoblastic leukemia in adults R Foà, R Bassan, A Vitale, L Elia, A Piciocchi, MC Puzzolo, M Canichella, ... New England Journal of Medicine 383 (17), 1613-1623, 2020 | 331 | 2020 |
| Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) C Girmenia, AM Raiola, A Piciocchi, A Algarotti, M Stanzani, L Cudillo, ... Biology of Blood and Marrow Transplantation 20 (6), 872-880, 2014 | 178 | 2014 |
| Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy C Girmenia, GM Rossolini, A Piciocchi, A Bertaina, G Pisapia, D Pastore, ... Bone marrow transplantation 50 (2), 282-288, 2015 | 177* | 2015 |
| Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic … MT Voso, S Fenu, R Latagliata, F Buccisano, A Piciocchi, MA Aloe-Spiriti, ... J Clin Oncol 31 (21), 2671-2677, 2013 | 172 | 2013 |
| Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic … MT Voso, S Fenu, R Latagliata, F Buccisano, A Piciocchi, MA Aloe-Spiriti, ... J Clin Oncol 31 (21), 2671-2677, 2013 | 172 | 2013 |
| GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia A Venditti, A Piciocchi, A Candoni, L Melillo, V Calafiore, R Cairoli, ... Blood, The Journal of the American Society of Hematology 134 (12), 935-945, 2019 | 167 | 2019 |
| Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness M Messina, I Del Giudice, H Khiabanian, D Rossi, S Chiaretti, S Rasi, ... Blood, The Journal of the American Society of Hematology 123 (15), 2378-2388, 2014 | 158 | 2014 |
| Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1) B Falini, K Macijewski, T Weiss, U Bacher, S Schnittger, W Kern, ... Blood, The Journal of the American Society of Hematology 115 (18), 3776-3786, 2010 | 143 | 2010 |
| Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients R Foà, I Del Giudice, A Cuneo, G Del Poeta, S Ciolli, F Di Raimondo, ... American journal of hematology 89 (5), 480-486, 2014 | 142 | 2014 |
| Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective … C Girmenia, A Bertaina, A Piciocchi, K Perruccio, A Algarotti, A Busca, ... Clinical Infectious Diseases 65 (11), 1884-1896, 2017 | 136 | 2017 |
| Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes MT Voso, V Santini, C Finelli, P Musto, E Pogliani, E Angelucci, G Fioritoni, ... Clinical cancer research 15 (15), 5002-5007, 2009 | 124 | 2009 |
| Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the I talian network on secondary leukemias L Fianchi, L Pagano, A Piciocchi, A Candoni, G Gaidano, M Breccia, ... American journal of hematology 90 (5), E80-E85, 2015 | 115 | 2015 |
| Deferasirox for transfusion‐dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS 0306 T rial) E Angelucci, V Santini, AA Di Tucci, G Quaresmini, C Finelli, A Volpe, ... European journal of haematology 92 (6), 527-536, 2014 | 106 | 2014 |
| Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the … A Symeonidis, A Van Biezen, L de Wreede, A Piciocchi, J Finke, D Beelen, ... British journal of haematology 171 (2), 239-246, 2015 | 103 | 2015 |
| PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy L Cicconi, M Divona, C Ciardi, T Ottone, A Ferrantini, S Lavorgna, ... Leukemia 30 (10), 1987-1992, 2016 | 91 | 2016 |
| Clinical features and prognostic factors in solitary plasmacytoma P Finsinger, S Grammatico, M Chisini, A Piciocchi, R Foà, MT Petrucci British journal of haematology 172 (4), 554-560, 2016 | 86 | 2016 |
| A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study S Chiaretti, A Vitale, M Vignetti, A Piciocchi, P Fazi, L Elia, B Falini, ... haematologica 101 (12), 1544, 2016 | 85 | 2016 |
| First report of the Gimema LAL1811 phase II prospective study of the combination of steroids with ponatinib as frontline therapy of elderly or unfit patients with Philadelphia … G Martinelli, A Piciocchi, C Papayannidis, S Paolini, V Robustelli, ... Blood 130, 99, 2017 | 75 | 2017 |
| Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial A Cortelezzi, M Sciumè, AM Liberati, D Vincenti, A Cuneo, G Reda, ... Leukemia 28 (3), 642-648, 2014 | 70 | 2014 |
